This study adds to the body of literature supporting the beneficial effects of semaglutide in people with overweight and obesity without diabetes, which is so necessary as we continue to navigate the complex landscape of insurance coverage of these medications in people who do not have diabetes, Shiara Ortiz-Pujols, MD, MPH, an obesity medicine physician at Staten Island University Hospital, told Healthline
Our protocol signals the body to maintain these areas
"The weight loss in clinical trials is even more substantial, and the most likely reason that it decreases orthopedic problems is because of the weight loss less stress on the joints and the decreased inflammation," Siegel added
PubMed Meng, S., Wang, L
Simple dosing Take the GLP-1 as directed using a simple, self-injection pen
Prepare for your appointment by documenting your current symptoms, particularly those related to weight management, energy levels, and metabolic health